Physiologically based biopharmaceutics modeling of regional and colon absorption in humans-Reference-Cited by-同舟云学术

Physiologically based biopharmaceutics modeling of regional and colon absorption in humans

Published:2023-05 Issue: Volume:186 Page:144-159
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Tannergren Christer,Jadhav Harshad,Eckernäs Emma,Fagerberg Jonas,Augustijns Patrick,Sjögren Erik

Funder

H2020 Marie Skłodowska-Curie Actions

European Union

Horizon 2020 Framework Programme

Horizon 2020

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference72 articles.

1. FDA, The Use of Physiologically Based Pharmacokinetic Analyses — Biopharmaceutics Applications for Oral Drug Product Development, Manufacturing Changes, and Controls.Guidance for Industry. DRAFT GUIDANCE, (2020).

2. Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report;Abend;AAPS J.,2018

3. Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report;Heimbach;Aaps J.,2019

4. Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies;Mitra;J Pharm Sci,2020

5. Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report;Mitra;J. Pharm. Sci.,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based in vitro – in vivo correlation of modified release oral formulations with non-linear intestinal absorption: A case study using mirabegron;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report;Molecular Pharmaceutics;2024-07-01

3. Computational insights into colonic motility: Mechanical role of mucus in homeostasis and inflammation;Computers in Biology and Medicine;2024-06

4. Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration;Pharmaceuticals;2024-01-30

5. Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor;Pharmaceutics;2023-12-04